Balyasny Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-166,263
| Closed | -$2.18M | – | 1917 |
|
|
2024
Q3 | $2.18M | Sell |
166,263
-118,036
| -42% | -$1.55M | ﹤0.01% | 1102 |
|
|
2024
Q2 | $4M | Sell |
284,299
-25,413
| -8% | -$357K | 0.01% | 883 |
|
|
2024
Q1 | $5.23M | Sell |
309,712
-471,803
| -60% | -$7.97M | 0.01% | 847 |
|
|
2023
Q4 | $11M | Buy |
+781,515
| New | +$11M | 0.02% | 604 |
|
|
2020
Q3 | – | Sell |
-97,687
| Closed | -$789K | – | 1048 |
|
|
2020
Q2 | $789K | Buy |
+97,687
| New | +$789K | 0.01% | 703 |
|